TrialClinical cancer research : an official journal of the American Association for Cancer Research2026

Biomarker Analysis from Patients with Metastatic PDAC Treated with TGFβ Antibody NIS793 plus Abraxane + Gemcitabine versus Abraxane + Gemcitabine Alone in a Phase II, Open-Label, Randomized Study.

Marc Pelletier et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.